Vanda Pharmaceuticals Inc. — Director's Dealing 2019

Aug 28, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2019-08-26

Reporting Person: DUGAN RICHARD W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-26	Common Stock	M	15000	$14.78	Acquired	50770	Direct
2019-08-26	Common Stock	S	15000	$14.85	Disposed	35770	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-26	Nonstatutory Stock Option (Right to Buy)	$14.78	M	15000	Disposed	2019-08-26	Common Stock (15000)	Direct

Footnotes

F1: Represents shares of common stock sold to cover the payment of the option exercise price (which represents 99.94% of the proceeds from the sales made by the Reporting Person) of the option, which was set to expire on August 26, 2019.

F2: The option vested in 12 equal monthly installments beginning on September 27, 2009.